Hartford HealthCare
13
3
3
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 13 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
40%
2 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors
Role: collaborator
Psilocybin Microdosing on Cognition, Mood and Quality of Life
Role: collaborator
Using Breathing Techniques to Ease Anxiety in ICU Patients Awaiting Heart Transplants
Role: lead
Promoting Self-Management of Breast and Nipple Pain With Technology (PROMPT) for Breastfeeding Women Study
Role: collaborator
Pelvic Floor Disorder Symptoms in Women Seeking Weight Loss Therapy
Role: lead
Adaptive Symptom Care Using Fish-Based Nutritional Directives Post Breast Cancer
Role: collaborator
The Recovery in Stroke Using PAP Study
Role: collaborator
Outcomes After Secondary Cytoreductive Surgery With or Without Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Followed by Systemic Combination Chemotherapy for Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Role: collaborator
Gemcitabine, Trastuzumab, and Pertuzumab in the Treatment of Metastatic HER2-Positive Breast Cancer After Prior Trastuzumab/Pertuzumab, or Pertuzumab Based Therapy
Role: collaborator
Improving Availability of Intranasal Naloxone
Role: collaborator
A Clinical Trial Using a New Medical Device to Evaluate Its Impact on IV Care and Clinical Complications
Role: collaborator
Prospective, Observational Study of Wellinks Effect on COPD Hospital Readmissions
Role: collaborator
Status Migrainosus - Differentiating Between Responders and Non-responders
Role: lead
All 13 trials loaded